White Paper

Developing Novel Biologics

Biologics are a fast-growing segment of the biopharmaceutical industry, resulting in novel, targeted treatment approaches. But manufacturers must file a successful Biologics License Application (BLA) in order to market their therapies.

This white paper outlines the analytical test methods used to validate your product’s safety and efficacy in support of BLA submissions.

To learn more about the methods used to validate your product's safety and efficacy, download the free white paper below.

View more articles about

Find related articles to you through the Nucleus